{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:34:34Z","timestamp":1792272874307,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002674","name":"Russian Academy of Sciences","doi-asserted-by":"publisher","award":["125020401357-4"],"award-info":[{"award-number":["125020401357-4"]}],"id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-63-00016"],"award-info":[{"award-number":["24-63-00016"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["FFSG-2024-0021"],"award-info":[{"award-number":["FFSG-2024-0021"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118397","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T07:45:42Z","timestamp":1764143142000},"page":"118397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis, biological evaluation, and in silico studies of pyridoxal\u2013amiridine hybrids as multitargeting anti-Alzheimer's disease agents"],"prefix":"10.1016","volume":"303","author":[{"given":"G.F.","family":"Makhaeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Grishchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Rudakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.V.","family":"Kovaleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.","family":"Boltneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Skornyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.G.","family":"Khudina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Shchegolkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.F.","family":"Zhilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.Yu.","family":"Astakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Pronkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.N.","family":"Timokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Lapshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Dubrovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Radchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.A.","family":"Palyulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya.V.","family":"Burgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.I.","family":"Saloutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.N.","family":"Charushin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-5723","authenticated-orcid":false,"given":"R.J.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118397_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/nu8020068","article-title":"B vitamins and the brain: mechanisms, dose and Efficacy--A review","volume":"8","author":"Kennedy","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2025.118397_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/cells7070084","article-title":"Vitamin B(6) and its role in cell metabolism and physiology","volume":"7","author":"Parra","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118397_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0891-5849(00)00462-7","article-title":"Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na+ + K+)-ATPase activity reduction in high glucose-treated human erythrocytes","volume":"30","author":"Jain","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118397_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jfda.2018.01.004","article-title":"Effects of vitamin B-6 supplementation on oxidative stress and inflammatory response in neonatal rats receiving hyperoxia therapy","volume":"26","author":"Lee","year":"2018","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.ejmech.2025.118397_bib5","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00018-005-5082-7","article-title":"Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage","volume":"62","author":"Voziyan","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118397_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmet.2019.08.003","article-title":"Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation","volume":"28","author":"Kassab","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ejmech.2025.118397_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.921611","article-title":"Pyridoxamine and aminoguanidine attenuate the abnormal aggregation of beta-tubulin and suppression of neurite outgrowth by glyceraldehyde-derived toxic advanced glycation end-products","volume":"13","author":"Ooi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118397_bib8","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1177\/15648265080292S119","article-title":"The worldwide challenge of the dementias: a role for B vitamins and homocysteine?","volume":"29","author":"Smith","year":"2008","journal-title":"Food Nutr. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2012.09.006","article-title":"Striatal dopamine receptors modulate the expression of insulin receptor, IGF-1 and GLUT-3 in diabetic rats: effect of pyridoxine treatment","volume":"696","author":"Anitha","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118397_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072128","article-title":"Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products","volume":"8","author":"Ahmad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118397_bib11","article-title":"Pharmacologic approaches against advanced glycation end products (AGEs) in diabetic cardiovascular disease","volume":"4","author":"Nenna","year":"2015","journal-title":"Res. Cardiovasc. Med."},{"key":"10.1016\/j.ejmech.2025.118397_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1568026623666221208125203","article-title":"Chemical modifications of pyridoxine for biological applications: an overview","volume":"23","author":"Pawar","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11172-019-2504-5","article-title":"Chemistry of pyridoxine in drug design","volume":"68","author":"Shtyrlin","year":"2019","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib14","unstructured":"Pyridoxine: Uses, Interactions, Mechanism of Action | Drugbank Online."},{"key":"10.1016\/j.ejmech.2025.118397_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2431832","article-title":"Evaluation of hydrazone and N-acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against alzheimer's disease","volume":"39","author":"Bartolic","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1515\/hc-2022-0002","article-title":"\u201cclick\u201d assembly of novel dual inhibitors of AChE and MAO-B from pyridoxine derivatives for the treatment of Alzheimer's disease","volume":"28","author":"Jia","year":"2022","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2025.118397_bib17","doi-asserted-by":"crossref","first-page":"26006","DOI":"10.1039\/D0RA04942E","article-title":"Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine-triazoles as anti-alzheimer's agents","volume":"10","author":"Pal","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118397_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bioorg.2017.02.016","article-title":"Pyridoxine-resveratrol hybrids mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of alzheimer's disease","volume":"71","author":"Yang","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/med.21434","article-title":"Drugs in clinical trials for alzheimer's Disease: the major trends","volume":"37","author":"Bachurin","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118397_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/ijms24010543","article-title":"Pathogenesis of dementia","volume":"24","author":"Blaszczyk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118397_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial Nature of Alzheimer's Disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.118397_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed. Rep"},{"key":"10.1016\/j.ejmech.2025.118397_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2025.118397_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fnmol.2017.00339","article-title":"Biometal dyshomeostasis and toxic metal accumulations in the development of alzheimer's disease","volume":"10","author":"Li","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118397_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of alzheimer's disease: current status and new perspectives","volume":"2","author":"Scarpini","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2025.118397_bib27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2741\/4285","article-title":"An update on drug treatment options of alzheimer's disease","volume":"19","author":"Allgaier","year":"2014","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.ejmech.2025.118397_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543784.15.1.1","article-title":"Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease","volume":"15","author":"Martinez","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2025.118397_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1570159X113116660047","article-title":"Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer's disease","volume":"12","author":"Agis-Torres","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2025.118397_bib30","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/med.21699","article-title":"From combinations to multitarget-directed ligands: a continuum in Alzheimer's disease polypharmacology","volume":"41","author":"Albertini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118397_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11172-023-3718-0","article-title":"Multipharmacophore strategy in medicinal chemistry for the design of drugs for the treatment of Alzheimer's and some other neurodegenerative diseases","volume":"72","author":"Bachurin","year":"2023","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1570159X1203140511153200","article-title":"Multi-target directed drugs: a modern approach for design of new drugs for the treatment of Alzheimer's Disease","volume":"12","author":"Dias","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2025.118397_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cbi.2019.05.020","article-title":"Overview of novel multifunctional agents based on conjugates of gamma-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease","volume":"308","author":"Makhaeva","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118397_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","article-title":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease","volume":"151","author":"Ismaili","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.118397_bib35","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.1134\/S1070363223150161","article-title":"Multifunctional inhibitors of cholinesterases for the therapy of Alzheimer's disease (A Review)","volume":"93","author":"Makhaeva","year":"2024","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.118397_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400819","article-title":"Conjugates of amiridine and salicylic derivatives as promising multifunctional CNS agents for potential treatment of Alzheimer's disease","volume":"358","author":"Makhaeva","year":"2025","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.118397_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104974","article-title":"Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment","volume":"112","author":"Makhaeva","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib39","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1007\/s11172-022-3668-y","article-title":"Synthesis and study of the biological activity of thiourea-containing amiridine derivatives as potential multi-target drugs for the treatment of Alzheimer's disease","volume":"71","author":"Makhaeva","year":"2022","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/molecules27031060","article-title":"Bis-Amiridines as acetylcholinesterase and butyrylcholinesterase inhibitors: N-functionalization determines the multitarget anti-alzheimer's activity profile","volume":"27","author":"Makhaeva","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118397_bib41","article-title":"Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with potential to block \u03b2 amyloid aggregation","volume":"357","author":"Khudina","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.118397_bib42","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s11172-024-4293-8","article-title":"Synthesis of conjugates of ipidacrine with oxa\/azaheterocycles and their potential as agents for the treatment of Alzheimer's disease","volume":"73","author":"Khudina","year":"2024","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116399","article-title":"Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease","volume":"173","author":"Mezeiova","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118397_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500723","article-title":"Synthesis of Tacrine\/Amiridine conjugates with Aminomethylidene derivatives of trifluoroacetoacetic ester and their biological potential for the therapy of Alzheimer's Disease","author":"Grishchenko","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118397_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1039\/c0md00256a","article-title":"Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase","volume":"2","author":"Bornstein","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2025.118397_bib46","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1021\/acs.joc.2c00724","article-title":"Shared hydrogen atom location and chemical composition in picolinic acid and pyridoxal hydrochloride derivatives determined by X-ray crystallography","volume":"87","author":"Crespi","year":"2022","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1246\/bcsj.41.161","article-title":"A new synthesis of pyridoxal-5-phosphate","volume":"41","author":"Iwanami","year":"1968","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2025.118397_bib48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1134\/S1070363215020309","article-title":"Pyridoxal-derived Schiff's bases","volume":"85","author":"Kibardina","year":"2015","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1134\/S1070363216030178","article-title":"Pyridoxal reactions with amines and aliphatic diamines","volume":"86","author":"Kibardina","year":"2016","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib50","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s11172-019-2507-2","article-title":"Cholinesterase and carboxylesterase inhibitors as pharmacological agents","volume":"68","author":"Makhaeva","year":"2019","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cbi.2016.05.002","article-title":"Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo","volume":"259","author":"Makhaeva","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118397_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cbi.2012.10.012","article-title":"Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects","volume":"203","author":"Makhaeva","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118397_bib53","series-title":"Evaluation of enzyme Inhibitors in Drug Discovery: a Guide for Medicinal Chemists and Pharmacologists","first-page":"53","article-title":"Reversible modes of inhibitor interactions with enzymes","author":"Copeland","year":"2013"},{"key":"10.1016\/j.ejmech.2025.118397_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/1735-5362.278711","article-title":"Synthesis and inhibitory activity of N-acetylpyrrolidine derivatives on alpha-glucosidase and alpha-amylase","volume":"15","author":"Sansenya","year":"2020","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2025.118397_bib55","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation","volume":"40","author":"De Ferrari","year":"2001","journal-title":"Biochem."},{"key":"10.1016\/j.ejmech.2025.118397_bib56","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","article-title":"Amyloid-cholinesterase interactions. Implications for alzheimer's disease","volume":"275","author":"Inestrosa","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118397_bib57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118397_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/molecules29020321","article-title":"Combining experimental and computational methods to produce conjugates of anticholinesterase and antioxidant pharmacophores with linker chemistries affecting biological activities related to treatment of alzheimer's disease","volume":"29","author":"Makhaeva","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118397_bib59","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/ijms24032285","article-title":"Conjugates of tacrine and salicylic acid derivatives as new promising multitarget agents for alzheimer's disease","volume":"24","author":"Makhaeva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118397_bib60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2025.118397_bib61","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2025.118397_bib62","doi-asserted-by":"crossref","first-page":"29719","DOI":"10.1074\/jbc.273.45.29719","article-title":"The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease","volume":"273","author":"Giulian","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1503\/jpn.120166","article-title":"Searching for an endogenous anti-alzheimer molecule: identifying small molecules in the brain that slow alzheimer disease progression by inhibition of ss-amyloid aggregation","volume":"38","author":"Meek","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ejmech.2025.118397_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103034","article-title":"Molecular dynamics simulations reveal the importance of amyloid-beta oligomer beta-sheet edge conformations in membrane permeabilization","volume":"299","author":"Matthes","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib65","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.118397_bib66","first-page":"535","article-title":"Oxidative stress in Alzheimer disease as a target for therapy","volume":"119","author":"Pohanka","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.ejmech.2025.118397_bib67","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant activity applying an improved ABTS radical cation decolorization assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118397_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113385","article-title":"Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold","volume":"218","author":"Makhaeva","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","article-title":"Ferric reducing\/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration","volume":"299","author":"Benzie","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2025.118397_bib70","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.3390\/molecules25245891","article-title":"New multifunctional agents based on conjugates of 4-Amino-2,3-polymethylenequinoline and butylated hydroxytoluene for Alzheimer's Disease treatment","volume":"25","author":"Makhaeva","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118397_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.foodchem.2005.02.018","article-title":"Antioxidant activity of water soluble vitamins in the TEAC (trolox equivalent antioxidant capacity) and the FRAP (ferric reducing antioxidant power) assays","volume":"96","author":"Gliszczynska-Swiglo","year":"2006","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib72","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.2174\/09298673113209990152","article-title":"Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants","volume":"20","author":"Chakrabarti","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib73","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40263-024-01093-0","article-title":"Targeting biometals in alzheimer's disease with metal chelating agents including coumarin derivatives","volume":"38","author":"Gucky","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2025.118397_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","article-title":"Advances in metal-induced oxidative stress and human disease","volume":"283","author":"Jomova","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2025.118397_bib75","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","article-title":"Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for alzheimer's disease","volume":"48","author":"Robert","year":"2015","journal-title":"Accounts of Chemical Research"},{"key":"10.1016\/j.ejmech.2025.118397_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2016.04.013","article-title":"Recent progress in multifunctional metal chelators as potential drugs for alzheimer's disease","volume":"327\u2013328","author":"Santos","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118397_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104596","article-title":"Tacrine - Benzothiazoles: novel class of potential multitarget anti-alzheimers drugs dealing with cholinergic, amyloid and mitochondrial systems","volume":"107","author":"Nepovimova","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cbi.2017.05.009","article-title":"N-stearoyl-l-Tyrosine inhibits the cell senescence and apoptosis induced by H(2)O(2) in HEK293\/Tau cells via the CB2 receptor","volume":"272","author":"Hu","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118397_bib79","doi-asserted-by":"crossref","first-page":"34735","DOI":"10.1039\/C9RA03848E","article-title":"Attenuated glutamate induced ROS production by antioxidative compounds in neural cell lines","volume":"9","author":"Xin","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118397_bib80","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/cells11223665","article-title":"Neuroprotective effects of neuropeptide Y on human neuroblastoma SH-SY5Y cells in glutamate excitotoxicity and ER stress conditions","volume":"11","author":"Palanivel","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118397_bib81","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF00764431","article-title":"Synthesis and pharmacological properties of amiridine analogs","volume":"23","author":"Zhidkova","year":"1989","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2025.118397_bib82","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.3390\/molecules25173915","article-title":"New hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as dual inhibitors of Acetyl- and butyrylcholinesterase and potential multifunctional agents for alzheimer's disease treatment","volume":"25","author":"Makhaeva","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118397_bib83","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.bmc.2017.09.028","article-title":"9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for alzheimer's disease treatment","volume":"25","author":"Makhaeva","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib84","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/bi00680a029","article-title":"Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding","volume":"14","author":"Taylor","year":"1975","journal-title":"Biochem."},{"key":"10.1016\/j.ejmech.2025.118397_bib85","series-title":"Gaussian 16 Revision C. 01. 2016","author":"Frisch","year":"2016"},{"key":"10.1016\/j.ejmech.2025.118397_bib86","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s11172-005-0329-x","article-title":"PRIRODA-04: a quantum-chemical program suite. New possibilities in the study of molecular systems with the application of parallel computing","volume":"54","author":"Laikov","year":"2005","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib87","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1063\/1.478522","article-title":"Toward reliable density functional methods without adjustable parameters: the PBE0 model","volume":"110","author":"Adamo","year":"1999","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118397_bib88","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1039\/b508541a","article-title":"Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to rn: design and assessment of accuracy","volume":"7","author":"Weigend","year":"2005","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118397_bib89","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118397_bib90","doi-asserted-by":"crossref","DOI":"10.1063\/1.3382344","article-title":"A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu","volume":"132","author":"Grimme","year":"2010","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118397_bib91","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1063\/1.460447","article-title":"A complete basis set model chemistry. II. Open-shell systems and the total energies of the first-row atoms","volume":"94","author":"Petersson","year":"1991","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118397_bib92","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jp810292n","article-title":"Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions","volume":"113","author":"Marenich","year":"2009","journal-title":"J. Chem. Phys. B"},{"key":"10.1016\/j.ejmech.2025.118397_bib93","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13062-020-00267-2","article-title":"AMDock: a versatile graphical tool for assisting molecular docking with autodock vina and Autodock4","volume":"15","author":"Valdes-Tresanco","year":"2020","journal-title":"Biol. Direct"},{"key":"10.1016\/j.ejmech.2025.118397_bib94","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib95","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib96","series-title":"The Worldwide Protein Data Bank","article-title":"Crystal structure of human butyryl cholinesterase","author":"Nicolet","year":"2003"},{"key":"10.1016\/j.ejmech.2025.118397_bib97","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1046\/j.1432-1033.2002.03271.x","article-title":"Solution structure of the Alzheimer amyloid \u03b2\u2010peptide (1\u201342) in an apolar microenvironment","volume":"269","author":"Crescenzi","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2025.118397_bib98","doi-asserted-by":"crossref","DOI":"10.2210\/pdb1iyt\/pdb","article-title":"Solution structure of the Alzheimer's disease amyloid beta-peptide (1-42)","author":"Crescenzi","year":"2003","journal-title":"The Worldwide protein data bank"},{"key":"10.1016\/j.ejmech.2025.118397_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1606","article-title":"Software update: the ORCA program system\u2014Version 5.0","volume":"12","author":"Neese","year":"2022","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118397_bib100","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1021\/jp9716997","article-title":"Quantum calculation of molecular energies and energy gradients in solution by a conductor solvent model","volume":"102","author":"Barone","year":"1998","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib101","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","article-title":"Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information","volume":"25","author":"Sushko","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2025.118397_bib102","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11172-016-1340-0","article-title":"Prediction of human intestinal absorption of drug compounds","volume":"65","author":"Radchenko","year":"2016","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.118397_bib103","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1134\/S1607672916050173","article-title":"Prediction of blood-brain barrier permeability of organic compounds","volume":"470","author":"Dyabina","year":"2016","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2025.118397_bib104","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.3390\/molecules25245901","article-title":"Towards deep neural network models for the prediction of the blood-brain barrier permeability for diverse organic compounds","volume":"25","author":"Radchenko","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118397_bib105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1134\/S1607672917020107","article-title":"Computer-aided estimation of the hERG-mediated cardiotoxicity risk of potential drug components","volume":"473","author":"Radchenko","year":"2017","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2025.118397_bib107","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2025.118397_bib109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2025.118397_bib110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2025.118397_bib111","first-page":"936","article-title":"Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118397_bib112","doi-asserted-by":"crossref","DOI":"10.18097\/BMCRM00051","article-title":"Protective effects of the natural sesquiterpene lactones against damage induced by glutamate and peroxide in SK-N-MC cells","volume":"1","author":"Dubrovskaya","year":"2018","journal-title":"BMCRM"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:51:30Z","timestamp":1781326290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":110,"alternative-id":["S0223523425011626"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118397","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, biological evaluation, and in silico studies of pyridoxal\u2013amiridine hybrids as multitargeting anti-Alzheimer's disease agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118397"}}